Rare diseases
Investigational molecules
Locations
245 Hammersmith Road, W6 8PW, United Kingdom
Orchard Therapeutics (Europe) Limited supports clinical research in Metachromatic Leukodystrophy, including late juvenile MLD and broader ARSA deficiency manifestations. The funded studies focus on neurological outcomes, disease progression, and restoration of enzyme activity in affected tissues.
Research activity in this area is centered on gene therapy approaches designed for inherited neurodegenerative disease.
Orchard Therapeutics (Europe) Limited runs clinical trials in conditions such as Metachromatic leukodystrophy, Mucopolysaccharidosis I, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
France
ItalyItalyItalyItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
